Therapeutic targets and novel anticancer agents for endocrine cancers
$802,871ZIAFY2024CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 38102328Paper 37450696Paper 37011647Paper 36925188Paper 36370152Paper 36302175Paper 35999087Paper 35861986Paper 35295984Paper 34735022Paper 34668970Paper 34536193Paper 34431366Paper 34415331Paper 34318891Paper 33986746Paper 33939050Paper 33933279Paper 33814188Paper 33732213Paper 33721134Paper 33644619Paper 33305158Paper 33220975Paper 32943182Paper 32698142Paper 32528402Paper 32228502Paper 32130200Paper 31531722Paper 31307109Paper 31277296Paper 31146085Paper 30865533Paper 30777201Paper 30652131Paper 30515264Paper 30414705Paper 30398411Paper 30327187Paper 30267071Paper 30250647Paper 30112163Paper 30084688Paper 29972703Paper 29971678Paper 29923016Paper 29659895Paper 29481652Paper 29408791Paper 29408534Paper 29334561Paper 29294023Paper 29264567Paper 29246404Paper 29165658Paper 29155309Paper 29134377Paper 29126554Paper 29108698Paper 29069375Paper 26206648Paper 25767039Paper 24781864Paper 24654752Paper 24590809Paper 24425879Paper 24423307Paper 24423287Paper 24262022Paper 23533247Paper 22751346Paper 22570059Paper 22170715Paper 22136831Paper 22048631Paper 21537869Paper 20231622Paper 19678746
View original record on NIH RePORTER →